{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:29:30Z","timestamp":1791142170114,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1124\/mol.111.074195","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T04:38:06Z","timestamp":1313037486000},"page":"920-929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Duration of Action of a Broad Range of Selective \u03ba-Opioid Receptor Antagonists Is Positively Correlated with c-Jun N-Terminal Kinase-1 Activation"],"prefix":"10.1016","volume":"80","author":[{"given":"Erica J.","family":"Melief","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Ivy","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"B\u00e9guin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William A.","family":"Carlezon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Grimwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Mitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Rorick-Kehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Chavkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.111.074195_bib1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cellsig.2006.09.008","article-title":"RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling","volume":"19","author":"Ajit","year":"2007","journal-title":"Cell Signal"},{"key":"10.1124\/mol.111.074195_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00213-010-1846-3","volume":"210","author":"Beardsley","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.111.074195_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/MMBR.00025-06","article-title":"Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases","volume":"70","author":"Bogoyevitch","year":"2006","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1124\/mol.111.074195_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF02245071","article-title":"Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on \u03ba-opioid agonists in the mouse writhing assay","volume":"115","author":"Broadbear","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.111.074195_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res"},{"key":"10.1124\/mol.111.074195_bib6","doi-asserted-by":"crossref","first-page":"29803","DOI":"10.1074\/jbc.M705540200","article-title":"Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase","volume":"282","author":"Bruchas","year":"2007","journal-title":"J Biol Chem"},{"key":"#cr-split#-10.1124\/mol.111.074195_bib7.1","unstructured":"Buezo ND, Pedregal-Tercero C, McKinzie DL, Mitch CH (2010), inventors"},{"key":"#cr-split#-10.1124\/mol.111.074195_bib7.2","unstructured":"Eli Lilly and Co., assignee. Kappa selective opioid receptor antagonist. U.S. patent 7,709,522. 2010 May 10."},{"key":"10.1124\/mol.111.074195_bib8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0022-3565(25)39577-7","article-title":"Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys","volume":"267","author":"Butelman","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.111.074195_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pharmthera.2009.05.008","article-title":"Kappa-opioid ligands in the study and treatment of mood disorders","volume":"123","author":"Carlezon","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.111.074195_bib10","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1021\/jm058264p","article-title":"N-substituted 4\u03b2-methyl-5-(3-hydroxyphenyl)-7\u03b1-amidomorphans are potent, selective \u03ba-opioid receptor antagonists","volume":"49","author":"Carroll","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/mol.111.074195_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","article-title":"Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist","volume":"501","author":"Carroll","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.111.074195_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.6120570","article-title":"Dynorphin is a specific endogenous ligand of the \u03ba-opioid receptor","volume":"215","author":"Chavkin","year":"1982","journal-title":"Science"},{"key":"10.1124\/mol.111.074195_bib13","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1046\/j.1460-9568.2002.02239.x","article-title":"Autoradiography of opioid and ORL1 ligands in opioid receptor triple knockout mice","volume":"16","author":"Clarke","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.111.074195_bib14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.bcp.2006.10.024","article-title":"Constitutive activity and inverse agonism at the alpha1 adrenoceptors","volume":"73","author":"Cotecchia","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.111.074195_bib15","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1021\/jm900756t","article-title":"Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic)","volume":"52","author":"Cueva","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/mol.111.074195_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"10.1124\/mol.111.074195_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2184.2009.00654.x","article-title":"The role of scaffold proteins in JNK signalling","volume":"43","author":"Engstr\u00f6m","year":"2010","journal-title":"Cell Prolif"},{"key":"10.1124\/mol.111.074195_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-005-2248-9","article-title":"Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS","volume":"180","author":"Garz\u00f3n","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.111.074195_bib19","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1074\/jbc.M407005200","article-title":"Activation of \u03bc-opioid receptors transfers control of G\u03b1 subunits to the regulator of G-protein signaling RGS9\u20132","volume":"280","author":"Garz\u00f3n","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.111.074195_bib20","doi-asserted-by":"crossref","unstructured":"Grimwood S, Lu Y, Schmidt AW, Vanase-Frawley MA, Sawant-Basak A, Miller E, McLean S, Freeman J, Wong S, McLaughlin JP, et al. (2011) Pharmacological characterization of 2-methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for kappa opioid receptors. J Pharmacol Exp Ther doi:10.1124\/jpet.111.185108.","DOI":"10.1124\/jpet.111.185108"},{"key":"10.1124\/mol.111.074195_bib21","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.111.074195_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ab.2009.06.018","article-title":"Characterization of serotonin 5-hydroxytryptamine-1A receptor activation using a phospho-extracellular-signal regulated kinase 2 sensor","volume":"393","author":"Huwiler","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.111.074195_bib23","series-title":"Guide for the Care and Use of Laboratory Animals","year":"1996"},{"key":"10.1124\/mol.111.074195_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.111.074195_bib25","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1124\/mol.107.040352","article-title":"Functional selectivity through protean and biased agonism: who steers the ship?","volume":"72","author":"Kenakin","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.111.074195_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","article-title":"The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system","volume":"28","author":"Land","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/mol.111.074195_bib27","doi-asserted-by":"crossref","first-page":"19168","DOI":"10.1073\/pnas.0910705106","article-title":"Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking","volume":"106","author":"Land","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.111.074195_bib28","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/mol.111.074195_bib29","doi-asserted-by":"crossref","first-page":"34631","DOI":"10.1074\/jbc.M304022200","article-title":"Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization","volume":"278","author":"McLaughlin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.111.074195_bib30","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1000751107","article-title":"Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling","volume":"107","author":"Melief","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.111.074195_bib31","unstructured":"Mitch CH, Quimby S, Matt J, Diaz N, Pedregal C, De La Torre M, Shi Q, Canada E, McKinzie D, Statnick M (2010) Discovery and characterization of a new kappa selective opioid receptor antagonist; 240th ACS National Meeting; 2010 Aug 22\u201326; Boston, MA. American Chemical Society, Washington DC."},{"key":"10.1124\/mol.111.074195_bib32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jcb.1222","article-title":"Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation","volume":"83","author":"Nandagopal","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1124\/mol.111.074195_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00213-002-1038-x","article-title":"Kappa opioid antagonist effects of the novel kappa antagonist 5\u2032-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys","volume":"163","author":"Negus","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.111.074195_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2011.04.017","article-title":"Identification of short-acting kappa-opioid receptor antagonists with anxiolytic-like activity","volume":"661","author":"Peters","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.111.074195_bib35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0024-3205(87)90585-6","article-title":"Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists","volume":"40","author":"Portoghese","year":"1987","journal-title":"Life Sci"},{"key":"10.1124\/mol.111.074195_bib36","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.npp.1301184","article-title":"Sumoylated RGS-RZ proteins act as scaffolds for mu-opioid receptors and G-protein complexes in mouse brain","volume":"32","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.111.074195_bib37","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1021\/jm030094y","article-title":"Identification of (3R)-7-hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist","volume":"46","author":"Thomas","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/mol.111.074195_bib38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1021\/jm030467v","article-title":"Importance of phenolic address groups in opioid kappa receptor selective antagonists","volume":"47","author":"Thomas","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/mol.111.074195_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.111.074195_bib40","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3565(25)31828-8","article-title":"A further characterization of the differential effects of leucine enkephalin, methionine enkephalin and their analogs on morphine-induced analgesia","volume":"211","author":"Vaught","year":"1979","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24033340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24033340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.111.074195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:38:46Z","timestamp":1739961526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24033340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0026895X24033340"],"URL":"https:\/\/doi.org\/10.1124\/mol.111.074195","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duration of Action of a Broad Range of Selective \u03ba-Opioid Receptor Antagonists Is Positively Correlated with c-Jun N-Terminal Kinase-1 Activation","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.111.074195","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}